Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics to Offer Genetic Testing Services to Practice Fusion Members

NEW YORK (GenomeWeb News) – Genetic testing laboratory Pathway Genomics today announced a partnership with Practice Fusion to offer its services to Practice Fusion's network of more than 150,000 medical professionals.

San Francisco-based Practice Fusion provides a free, web-based electronic medical record application to physicians. In a statement, Pathway Genomics Chief Medical Officer Michael Nova said that integrating his firm's services into Practice Fusion's EMR platform is a "critical step" in making actionable genetic information more accessible to physicians and patients.

Pathway conducts the analysis and interpretation of test results at its CLIA genetic testing lab and offers several DNA tests covering diet and exercise, drug response, carrier status, and complex health conditions.

Terms of today's agreement were not disclosed.

The deal follows an announcement in January by San Diego-based Pathway that it had joined Blue Shield's preferred provider organization network.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.